2013
DOI: 10.1378/chest.13-0076
|View full text |Cite
|
Sign up to set email alerts
|

Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
57
0
8

Year Published

2014
2014
2018
2018

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 136 publications
(68 citation statements)
references
References 37 publications
3
57
0
8
Order By: Relevance
“…Las comorbilidades de los pacientes respondían a la distribución usual, predominando la cardiovascular y neurológica. La severidad de ingreso a UCI de los pacientes con NAV fue superior a los de TAV, al ser comparados con el puntaje de SOFA 6,7 . Al evaluar los criterios de choque y mayor uso de vasopresores, estos fueron superiores en el grupo de NAV.…”
Section: Discussionunclassified
“…Las comorbilidades de los pacientes respondían a la distribución usual, predominando la cardiovascular y neurológica. La severidad de ingreso a UCI de los pacientes con NAV fue superior a los de TAV, al ser comparados con el puntaje de SOFA 6,7 . Al evaluar los criterios de choque y mayor uso de vasopresores, estos fueron superiores en el grupo de NAV.…”
Section: Discussionunclassified
“…Th e role of inhaled antibiotics in the setting of failure of systemic antibiotics is unclear [1]. Th e usual duration of treatment for earlyonset VAP is 8 days and longer in the case of late-onset VAP or if MDR organisms are suspected or identifi ed [39]- [41].…”
Section: Treatmentmentioning
confidence: 99%
“…The duration of VAP and HAP treatment should only exceed 7 days in isolated cases. Clinical studies and meta-analyses of VAP/HAP treatment duration found no differences in terms of mortality, pneumonia recurrence, treatment failure, or duration of invasive ventilation when comparing short (7-8 days) and longer (up to 15 days) treatment durations [150,170,181,182]. In a subgroup analysis of the study by Chastre et al [150] on VAP, it was shown that in pneumonias caused by non-fermenters such as P. aeruginosa and A. baumannii, for equal mortality rates, the group with shorter treatment (8 days) had more recurrent infections (40.6 vs. 25.5%).…”
Section: Nosocomial and Ventilatorassociated Pneumoniamentioning
confidence: 97%